Showing 6931-6940 of 10618 results for "".
- Study Compares TXA Delivery Methods in Rhinoplasty Outcomeshttps://reachmd.com/news/study-compares-txa-delivery-methods-in-rhinoplasty-outcomes/2486333/In a prospective comparative study published online ahead of print in Journal of Craniofacial Surgery, investigators evaluated the impact of different tranexamic acid (TXA) administration routes on postoperative recovery following implant-based rhinoplasty. A total of 82 patients undergo
- Parent Training Increased Active Mediation of Adolescents’ Smartphone Usehttps://reachmd.com/news/parent-training-increased-active-mediation-of-adolescents-smartphone-use-6session-trial/2486319/In a recent trial, parents who completed a training program reported higher levels of active mediation of adolescents’ smartphone use than a no-intervention control group, and the difference was reported as maintained at a two-month follow-up. The experiment enrolled parents of adolescents
- UC Systemwide Hypertension Program: Reported Population Outcomes and Implementation Featureshttps://reachmd.com/news/uc-systemwide-hypertension-program-reported-population-outcomes-and-implementation-features/2486317/A University of California (UC) initiative that embedded a standardized hypertension medication algorithm across its health system was associated with higher measured blood pressure control at the population level, according to
- Analysis: Long Waits for Pediatric Dermatology Appointments Across UShttps://reachmd.com/news/study-finds-long-waits-for-pediatric-dermatology-appointments-across-us/2486313/Children seeking dermatologic care in the US face long waits regardless of where they are referred, according to a research letter published online in JAMA Dermatology. Using a mystery caller design, investigators as
- FDA Approves Icotrokinra for Moderate-to-Severe Plaque Psoriasishttps://reachmd.com/news/fda-approves-icotyde-for-moderate-to-severe-plaque-psoriasis/2486305/Johnson & Johnson announced that the FDA has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and in pediatric patients 12 years and older who weigh at least 40 kg and are candidates for systemic therapy or phot
- Trace Pathogen Detections: Insights for Clinicianshttps://reachmd.com/news/trace-pathogen-detections-what-the-news-article-reports-for-clinicians/2486104/Ultra-sensitive food-safety testing can detect microbial signals at very low levels, raising questions about how to interpret a laboratory “positive” in terms of consumer risk. In a recent report on
- High Macrolide Resistance in Pediatric Mycoplasma pneumoniaehttps://reachmd.com/news/macrolide-resistance-pediatric-mycoplasma-pneumoniae/2486090/Pediatric surveillance from Beijing spanning 2017–2025 showed consistently high in vitro macrolide resistance among Mycoplasma pneumoniae isolates recovered acro
- Intelectin-2 Strengthens Mucosal Defense and Shows Activity Against Resistant Bacteriahttps://reachmd.com/news/intelectin2-mucosal-defense-resistant-bacteria/2486091/In a new study in Nature Communications, intelectin-2 is described as a gut lectin that recognizes the sugar galactose on mucins and
- Dermatology Residents Show Gains After Targeted Topical Formulation Educationhttps://reachmd.com/news/dermatology-residents-show-gains-after-targeted-topical-formulation-education/2486095/A small survey-based study found that dermatology residents from 3 training programs reported limited formal education in topical vehicle formulation science, but showed improved comfort, confidence, and knowledge after a targeted educational intervention.
- Severe COVID or Flu and Later Lung Cancer Riskhttps://reachmd.com/news/severe-covid-or-flu-and-later-lung-cancer-risk/2486065/UVA-led research reports evidence linking severe r